嚐高美(08371.HK)斥2,000萬人幣與雙匯餐飲設合營 發展內地餐飲業務
嚐高美集團(08371.HK)公布,公司全資附屬嚐高美中國與雙匯餐飲已經訂立合資協議,同意成立合資公司,以發展中國的餐飲業務。根據協議,合資公司將由嚐高美中國擁有60%,及由雙匯餐飲擁有40%。總投資額為5,000萬元人民幣(下同),其中嚐高美中國出資3,000萬元。
合資公司總部設在上海,將尋找合適的地點來開設集團現有的品牌餐廳,例如多賀野、Parkview、Rakuraku拉麵等。
雙匯餐飲為雙匯發展(000895.SZ)的附屬公司,雙匯發展則是萬洲國際(00288.HK)的附屬公司。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.